Picture of Biodesix logo

BDSX Biodesix Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m-8.14%
3m-27.23%
6m-22.21%
1yr-36.55%
Volume Change (%)
10d/3m-44.98%
Price vs... (%)
52w High-37.56%
50d MA-18.89%
200d MA-10.12%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-62.94%
Return on Equity-414.09%
Operating Margin-84.22%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Biodesix EPS forecast chart

Profile Summary

Biodesix, Inc. (Biodesix) is a data-driven diagnostic solutions company. Biodesix is focused on using technologies with its artificial intelligence platform to discover, develop, and commercialize solutions for clinical unmet needs in lung disease. Biodesix is providing diagnostic testing services associated with blood-based lung tests; coronavirus disease tests and providing biopharmaceutical companies with services that include diagnostic research, clinical research, development, and testing services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Its blood-based lung cancer tests include Nodify XL2 and Nodify CDT tests, and GeneStrat and VeriStrat tests. Biodesix also offers SARS-CoV-2 tests under the Biodesix WorkSafe testing program, such as Bio-Rad SARS-CoV-2 ddPCR test, Platelia SARS-CoV-2 Total Ab test and cPass SARS-CoV-2 Neutralizing Antibody testing.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
December 23rd, 2005
Public Since
October 28th, 2020
No. of Employees
217
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Market
Shares in Issue
96,942,061

BDSX Share Price Performance

Upcoming Events for BDSX

Q1 2024 Biodesix Inc Earnings Release

Biodesix Inc Annual Shareholders Meeting

Q2 2024 Biodesix Inc Earnings Release

Similar to BDSX

Picture of Airsculpt Technologies logo

Airsculpt Technologies

us flag iconNASDAQ Global Market

Picture of Burning Rock Biotech logo

Burning Rock Biotech

us flag iconNASDAQ Global Market

Picture of Exagen logo

Exagen

us flag iconNASDAQ Global Market

Picture of Extend Health LLC logo

Extend Health LLC

us flag iconNASDAQ Global Market

Picture of Fulgent Genetics logo

Fulgent Genetics

us flag iconNASDAQ Global Market

FAQ